Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study
Keyword(s):
Phase 3
◽
Keyword(s):
2011 ◽
Vol 90
(12)
◽
pp. 1427-1439
◽
Keyword(s):
2020 ◽
Vol 61
(6)
◽
pp. 1323-1333
◽
Keyword(s):